Yin-xia Chen

发表

Low dose of homoharringtonine and cytarabine combined with granulocyte colony-stimulating factor priming on the outcome of relapsed or refractory acute myeloid leukemia

Liu-fang Gu, Wang-gang Zhang, Fangxia Wang, 2011, Journal of Cancer Research and Clinical Oncology.

Effect of granulocyte colony-stimulating factor priming combined with low-dose cytarabine and homoharringtonine in higher risk myelodysplastic syndrome patients.

Liu-fang Gu, Wang-gang Zhang, Fangxia Wang, 2016, Leukemia research.

Regulation of expression of MLAA-34 gene through transcriptional factors E2F1 and MZF-1.

B. Lei, Wanggang Zhang, Xing-mei Cao, 2019, International journal of clinical and experimental pathology.

Management of cytokine release syndrome related to CAR-T cell therapy

B. Lei, Wanggang Zhang, Liu-fang Gu, 2019, Frontiers of Medicine.

Durable remissions with BCMA-specific chimeric antigen receptor (CAR)-modified T cells in patients with refractory/relapsed multiple myeloma.

B. Lei, Wanggang Zhang, Liu-fang Gu, 2017 .

Extended Course and Increased Dose of Initial Chemotherapy for Extranodal Nasal Type Natural Killer/T (NK/T)-Cell Lymphoma in Patients <60 Years Old: A Single-Center Retrospective Cohort Study

B. Lei, Wanggang Zhang, Liu-fang Gu, 2016, Medical science monitor : international medical journal of experimental and clinical research.

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia

Wanggang Zhang, Fangxia Wang, Xing-mei Cao, 2018, Medicina Clínica (English Edition).

Granulocyte colony stimulating factor priming chemotherapy is more effective than standard chemotherapy as salvage therapy in relapsed acute myeloid leukemia.

Wanggang Zhang, Fangxia Wang, Xing-mei Cao, 2017, Medicina clinica.

Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura

Xing-mei Cao, Yin-xia Chen, A. He, 2005, Acta Pharmacologica Sinica.

Visfatin promotes the malignancy of human acute myeloid leukemia cells via regulation of IL‐17

B. Lei, Yong Yu, Huan Yao, 2019, European journal of pharmacology.

Comparison of porcine anti‐human lymphocyte globulin and rabbit anti‐human thymocyte globulin in the treatment of severe aplastic anemia: a retrospective single‐center study

Wanggang Zhang, Xing-mei Cao, Yin-xia Chen, 2016, European journal of haematology.

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Saijuan Chen, Hua Jiang, Jian-yong Li, 2022, Journal of Hematology & Oncology.

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

B. Lei, Y. Geng, Zong-fang Li, 2018, Journal of Hematology & Oncology.

Long non-coding RNA RPPH1 promotes the proliferation, invasion and migration of human acute myeloid leukemia cells through down-regulating miR-330-5p expression

B. Lei, Wanggang Zhang, Xing-mei Cao, 2019, EXCLI journal.

High-Intensity Chemotherapy is Associated with Better Prognosis in Young Patients with High-Risk Diffuse Large B-Cell Lymphoma: A 10-Year Single-Center Retrospective Cohort Study

Wanggang Zhang, Xing-mei Cao, Yin-xia Chen, 2016, Medical science monitor : international medical journal of experimental and clinical research.

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease--a Single Institution Observation in China

B. Lei, Liu-fang Gu, Fangxia Wang, 2020 .

Updated Analysis of a Phase 1, Open-Label Study of LCAR-B38M, a Chimeric Antigen Receptor T Cell Therapy Directed Against B-Cell Maturation Antigen, in Patients with Relapsed/Refractory Multiple Myeloma

Zong-fang Li, B. Lei, Y. Geng, 2018, Blood.

Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

Fangxia Wang, Xing-mei Cao, Yin-xia Chen, 2008, American journal of hematology.

The expression and functional characterization associated with cell apoptosis and proteomic analysis of the novel gene MLAA-34 in U937 cells.

Wen-juan Zhang, Liu-fang Gu, Xing-mei Cao, 2013, Oncology reports.

The expression and functional characterization associated with cell apoptosis and proteomic analysis of the novel gene MLAA-34 in U 937 cells

Wen-juan Zhang, Xing-mei Cao, Yin-xia Chen, 2012 .

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

B. Lei, Y. Geng, Zong-fang Li, 2019, Blood.

[Immunological screening for multiple myeloma-associated antigens and their bioinformatics analysis].

Ming Liu, Gang Chen, Xing-mei Cao, 2006, Zhongguo shi yan xue ye xue za zhi.

Leukemia-associated gene MLAA-34 reduces arsenic trioxide-induced apoptosis in HeLa cells via activation of the Wnt/β-catenin signaling pathway

B. Lei, Wanggang Zhang, Yin-xia Chen, 2017, PloS one.

C59T mutation in exon 2 of monocytic leukemia-associated antigen-34 gene indicates a high risk of recurrence of acute myeloid leukemia

B. Lei, Xin Meng, Wanggang Zhang, 2017, Oncology letters.

Association of the four common polymorphisms in interleukin-10 (rs1800890, rs1800896, rs1800871, and rs1800872) with non-Hodgkin's lymphoma risk: a meta-analysis.

Z. Dai, Xing-mei Cao, Yin-xia Chen, 2014, International journal of clinical and experimental medicine.

[Therapeutic effects of porcine versus rabbit antithymocyte globulins for treatment of severe aplastic anemia].

Xing-mei Cao, Yin-xia Chen, A. He, 2016, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[Retrospective observation of curative effects on MDS refractory anemia with combination of all-trans retinoic acid, 1, 25-dihydroxyvitamin D3 and androgen].

Xing-mei Cao, Yin-xia Chen, A. He, 2005, Zhongguo shi yan xue ye xue za zhi.

MLAA-34 knockdown shows enhanced antitumor activity via JAK2/STAT3 signaling pathway in acute monocytic leukemia

Yanping Zhang, B. Lei, Xin Meng, 2020, Journal of Cancer.

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Liu-fang Gu, Fangxia Wang, Xing-mei Cao, 2022, Journal of Medical Case Reports.

Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan.

Yin-xia Chen, JingKang Sun, Yun Yang, 2007, Zhongguo shi yan xue ye xue za zhi.